156 related articles for article (PubMed ID: 27816383)
1. Role of Interleukin-22 in chronic liver injury.
Carmo RF; Cavalcanti MSM; Moura P
Cytokine; 2017 Oct; 98():107-114. PubMed ID: 27816383
[TBL] [Abstract][Full Text] [Related]
2. Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis.
Fabre T; Molina MF; Soucy G; Goulet JP; Willems B; Villeneuve JP; Bilodeau M; Shoukry NH
Sci Immunol; 2018 Oct; 3(28):. PubMed ID: 30366940
[TBL] [Abstract][Full Text] [Related]
3. The Interleukin-20 Cytokine Family in Liver Disease.
Caparrós E; Francés R
Front Immunol; 2018; 9():1155. PubMed ID: 29892294
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C.
Wu LY; Liu S; Liu Y; Guo C; Li H; Li W; Jin X; Zhang K; Zhao P; Wei L; Zhao J
Clin Immunol; 2015 May; 158(1):77-87. PubMed ID: 25771172
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of liver injury to evaluate paracrine and endocrine effects of bone marrow mesenchymal stem cells.
Huang CK; Lee SO; Luo J; Wang R; Dang Q; Chang C
Methods Mol Biol; 2014; 1213():69-79. PubMed ID: 25173375
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
7. Type 3 cytokines in liver fibrosis and liver cancer.
Molina MF; Abdelnabi MN; Fabre T; Shoukry NH
Cytokine; 2019 Dec; 124():154497. PubMed ID: 30097286
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis - mouse models and relevance in human liver diseases.
Mederacke I
Z Gastroenterol; 2013 Jan; 51(1):55-62. PubMed ID: 23315652
[TBL] [Abstract][Full Text] [Related]
9. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases.
Al-Shaebi F; Wenzhang L; Hezam K; Almezgagi M; Wei L
Int Immunopharmacol; 2020 Dec; 89(Pt B):107023. PubMed ID: 33129098
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis: a dynamic and potentially reversible process.
Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors in acute liver injury and regeneration.
Chen Y; Sun R
Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of the atypical cadherin FAT1 in chronic liver disease.
Valletta D; Czech B; Thasler WE; Müller M; Bosserhoff AK; Hellerbrand C
Biochem Biophys Res Commun; 2012 Sep; 426(3):404-8. PubMed ID: 22959770
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.
Seo W; Eun HS; Kim SY; Yi HS; Lee YS; Park SH; Jang MJ; Jo E; Kim SC; Han YM; Park KG; Jeong WI
Hepatology; 2016 Aug; 64(2):616-31. PubMed ID: 27178735
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
[TBL] [Abstract][Full Text] [Related]
16. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
17. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
Yi HS; Jeong WI
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():99-104. PubMed ID: 23855303
[TBL] [Abstract][Full Text] [Related]
18. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.
Naseem S; Hussain T; Manzoor S
Cytokine Growth Factor Rev; 2018 Feb; 39():36-45. PubMed ID: 29361380
[TBL] [Abstract][Full Text] [Related]
20. Liver architecture, cell function, and disease.
Ishibashi H; Nakamura M; Komori A; Migita K; Shimoda S
Semin Immunopathol; 2009 Sep; 31(3):399-409. PubMed ID: 19468732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
